期刊
ONCOTARGET
卷 5, 期 19, 页码 9472-9483出版社
IMPACT JOURNALS LLC
DOI: 10.18632/oncotarget.2418
关键词
miR-382; osteosarcoma growth; chemoresistance
资金
- China International Medical Foundation [CIMF-F-H001-240]
- National Natural Science Foundation of China [81402216]
- Beijing Nova Program [Z141107001814097]
- Military youth support program of China [13QNP173]
Dysregulation of miRNAs is involved in osteosarcoma (OS). Here, we demonstrate that miR-382 is decreased in specimens of OS patients with a poor chemoresponse compared to those with a good chemoresponse. In addition, our clinical data show that decreased miR-382 was associated with poor survival in OS patients. Overexpression of miR-382 inhibited cell growth and chemoresistance by targeting KLF12 and HIPK3, respectively. In contrast, inhibition of miR-382 or overexpression of target genes stimulated OS cell growth and chemoresistance both in vitro and in vivo. Taken together, these findings suggest that miR-382 is a tumor suppressor miRNA and induction of miR-382 is a potential strategy to inhibit OS progression.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据